galantamine has been researched along with 1,4-dihydroquinoline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barré, L; Foucout, L; Gourand, F; Levacher, V; Oudeyer, S; Papamicaël, C; Petit, S; Ţînţaş, ML | 1 |
1 other study(ies) available for galantamine and 1,4-dihydroquinoline
| Article | Year |
|---|---|
New developments in redox chemical delivery systems by means of 1,4-dihydroquinoline-based targetor: application to galantamine delivery to the brain.
Topics: Acetylcholinesterase; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Drug Delivery Systems; Galantamine; Humans; Molecular Structure; Oxidation-Reduction; Quinolines | 2014 |